163 related articles for article (PubMed ID: 14870506)
1. [Diabetic nephropathy].
Metsärinne K
Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
[No Abstract] [Full Text] [Related]
2. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
3. [Pharmacological prevention and treatment of diabetic nephropathy].
Aitio ML
Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
[No Abstract] [Full Text] [Related]
4. Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
Jacobsen PK; Rossing P; Parving HH
Nephrol Dial Transplant; 2006 Jul; 21(7):2030-1. PubMed ID: 16449277
[No Abstract] [Full Text] [Related]
5. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin and its inhibition: a nephrologist point of view.
Kalra V; Agarwal SK; Wani M
J Assoc Physicians India; 2002 Oct; 50():1270-80. PubMed ID: 12568213
[No Abstract] [Full Text] [Related]
7. Optimal inhibition of renin angiotensin system to salvage 'at risk' diabetic kidneys--emerging Indian evidence.
Shah SN; Bansode BR; Kamath SA
J Assoc Physicians India; 2004 Mar; 52():183-6. PubMed ID: 15636305
[No Abstract] [Full Text] [Related]
8. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
Parving HH
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
[No Abstract] [Full Text] [Related]
9. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
[No Abstract] [Full Text] [Related]
14. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
15. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
16. [Kidney failure, proteinuria, and diabetic nephropathy].
Collart F
Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
[TBL] [Abstract][Full Text] [Related]
17. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
18. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Katavetin P; Katavetin P
N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
[No Abstract] [Full Text] [Related]
19. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
Raij L
Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors and diabetic renal disease. ACE inhibitors may prevent progression from incipient to clinical nephropathy.
Gilbert RE; Jerums G
Med J Aust; 1994 Nov; 161(10):583-4. PubMed ID: 7968725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
